Brief: Mabion Resigns From Further Implementation Of MabionEGFR Research Project
24/02/2022 07:38
Feb 24 (Reuters) - Mabion SA MABP.WA :
* RESIGNS FROM FURTHER IMPLEMENTATION OF MABIONEGFR
RESEARCH
PROJECT
* MANAGEMENT BELIEVES IMPLEMENTATION OF PROJECT IS
UNJUSTIFIED
Source text for Eikon: ID:nEM1kp4Wma
Further company coverage: MABP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys